Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Functional consequences of genetic variation in sodium channel modifiers in early onset lone atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Socio-demographic and cardiovascular disease risk factors associated with dementia: Results of a cross-sectional study from Lebanon

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reply to "Is diabetes preventable in the general population?"

    Research output: Contribution to journalComment/debateResearch

  4. Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Subtypes in BRCA-mutated breast cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Observational studies of aspirin use and breast cancer risk have provided inconsistent results. The occurrence of contralateral breast cancer (CBC) among breast cancer survivors may serve as a useful high-risk model to identify preventive drug effects. Using this model, we examined the association between post-diagnosis use of low-dose aspirin and risk of CBC. We identified all women recorded with a first primary breast cancer in the Danish Breast Cancer Cooperative Group Database between 1996 and 2012. Information on drug use, tumor and patient characteristics, treatment, and CBC was obtained from nationwide registries. In the main analysis, we defined time-varying post-diagnosis low-dose aspirin use as two or more prescriptions filled during follow-up and applied a one-year exposure lag. Cox proportional hazard regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between post-diagnosis low-dose aspirin use and CBC risk. Among 52,723 breast cancer patients, 1,444 women developed CBC during a median follow-up of 4.8 years. The adjusted HR for CBC associated with post-diagnosis use of low-dose aspirin was 0.91 (95% CI: 0.75-1.09). We observed no substantial variation in HRs according to pattern of low-dose aspirin use or estrogen receptor status of the first or the contralateral breast cancer. In conclusion, this large nationwide cohort study of breast cancer survivors does not provide strong evidence suggesting an association between post-diagnosis use of low-dose aspirin and risk of CBC.

Original languageEnglish
JournalPreventive Medicine
Volume116
Pages (from-to)186-193
Number of pages8
ISSN0091-7435
DOIs
Publication statusPublished - Nov 2018

ID: 55905674